Success Metrics

Clinical Success Rate
97.8%

Based on 131 completed trials

Completion Rate
98%(131/134)
Active Trials
9(6%)
Results Posted
21%(28 trials)
Terminated
3(2%)

Phase Distribution

Ph phase_4
8
5%
Ph phase_1
126
82%
Ph not_applicable
4
3%
Ph phase_3
4
3%
Ph early_phase_1
2
1%
Ph phase_2
9
6%

Phase Distribution

128

Early Stage

9

Mid Stage

12

Late Stage

Phase Distribution153 total trials
Early Phase 1First-in-human
2(1.3%)
Phase 1Safety & dosage
126(82.4%)
Phase 2Efficacy & side effects
9(5.9%)
Phase 3Large-scale testing
4(2.6%)
Phase 4Post-market surveillance
8(5.2%)
N/ANon-phased studies
4(2.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.6%

131 of 137 finished

Non-Completion Rate

4.4%

6 ended early

Currently Active

9

trials recruiting

Total Trials

154

all time

Status Distribution
Active(13)
Completed(131)
Terminated(6)
Other(4)

Detailed Status

Completed131
Recruiting7
Not yet recruiting4
unknown4
Terminated3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
154
Active
9
Success Rate
97.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.3%)
Phase 1126 (82.4%)
Phase 29 (5.9%)
Phase 34 (2.6%)
Phase 48 (5.2%)
N/A4 (2.6%)

Trials by Status

completed13185%
not_yet_recruiting43%
recruiting75%
active_not_recruiting21%
terminated32%
unknown43%
withdrawn32%

Recent Activity

Clinical Trials (154)

Showing 20 of 154 trialsScroll for more
NCT07855250Phase 1

An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition

Recruiting
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT06813924Phase 1

A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

Completed
NCT07838987Phase 1

A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

Completed
NCT06701812Phase 2

Digoxin Medulloblastoma Study

Recruiting
NCT07785934Phase 1

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

Recruiting
NCT07567781Phase 1

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

Completed
NCT05614739Phase 1

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Recruiting
NCT07570082Phase 1

Drug-Drug Interaction Study of Atumelnant in Healthy Participants

Completed
NCT07047209Phase 2

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT07339722Phase 1

A Study of LY4515100 in Healthy Participants

Recruiting
NCT06717269Phase 1

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed
NCT07118215Phase 1

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Completed
NCT04621669Phase 1

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Completed
NCT07321509Phase 4

Digoxin After Acute Heart Failure (DIG-DICA)

Recruiting
NCT06588699Phase 2

Digoxin In NASH (CODIN)

Recruiting
NCT06186622Phase 1

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Completed
NCT03783429Phase 4

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Completed
NCT02783040Phase 1

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Completed
NCT07502001Phase 1

Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
154